Research notes

Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions through online and physical stores in North America and internationally. The company’s product offering through its stores includes merchandise and content purchased for resale, and products offered by third-party sellers. It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Rings, Blink, eero, and Echo, and develops and produces media content.

Honeywell International is a world-wide diversified technology and manufacturing company. It consists of four key segments: (1) Aerospace, (2) Performance Materials & Technologies, (3) Building Technologies, and (4) Safety & Productivity Solutions. The company was founded in 1885 and is headquartered in Charlotte, North Carolina, United States.

SharkNinja (SN.NYS) is a US based, global consumer appliance company. The company operates two core and high-quality brands: 1) Shark – home care and cleaning products (vacuums/steam mops); and 2) Ninja – kitchen appliances (blenders/air fryers/food processors).

Nestlé SA is the world’s largest food and beverage company. It engages in the manufacture, supply and production of prepared dishes and cooking aids, milk-based products, pharmaceuticals and ophthalmic goods, baby foods and cereals.

DNL’s 1H26 result was materially stronger than expected. After a stronger than expected 1H26, DNL would have upgraded its FY26 Explosives guidance had it not been for a stronger AUD, cost headwinds given the conflict in the Middle East and stranded costs post the sale of Phosphate Hill. We have made material revisions to our FY26 forecasts reflecting the sale of Phosphate Hill for a poor price. Moving forward, DNL is now a pure play explosives company. We have made modest upgrades to FY27/28. In its first year with no Fertilisers, DNL is trading on a fair FY27F PE of 17.9x and EV/EBITDA of 9.3x. We maintain a Hold rating with a new price target of A$3.46.

FY26 guidance was downgraded on China Albumin price pressure, US Ig channel inventory normalisation and other impacts (paused Iran sales, lower Hemgenix and and Iron sales), combined with a further cUS$5bn in flagged impairments. Importantly, issues are framed as primarily executional rather than structural, with infrastructure overbuild, organisational complexity, and weak commercial execution cited, while underlying demand and industry structure remain healthy. Encouragingly, Seqirus is performing better than expected, Ig demand remains mid-to-high single digit, and there are early signs of plasma share stabilisation. While forward earnings visibility remains limited, we believe the current valuation increasingly discounts a structurally impaired plasma franchise, which we do not believe the current industry dynamics support. We reduce FY26-28 forecasts and lower our blended DCF, PE and EV/EBITDA-based target price to A$147.59. Given CSL’s global leadership positions, structurally growing end markets and operational initiatives, we retain a BUY rating.

SKY continues to advance Tallebung toward development, with approvals momentum building and drilling continuing to support resource growth and project confidence. Recent drilling has returned high-grade tin mineralisation alongside meaningful silver and tungsten results, with both commodities trading at or near all-time highs. We maintain our SPECULATIVE BUY rating and A$0.35ps price target, uplift a function of an increase to our bull case following sustained tin price appreciation.

MQG delivered a very strong FY26 result with NPAT (A$4.8bn) up +30% on the pcp and +8% above company-compiled consensus. Whilst acknowledging this result was aided by significant volatility in commodity markets that assisted CGM, MQG’s performance was generally strong across the board. We increase our MQG FY27F/FY28F EPS by +9%/+2%. Our price target rises to A$248 (previously A$223) on our earnings changes and a valuation roll-forward. MQG is a quality franchise, and a proven performer, but with <10% upside to our PT, we maintain our Hold call. We increase our MQG FY27F/FY28F EPS by +9%/+2%. Our price target rises to A$248 (previously A$223) on our earnings changes and a valuation roll-forward.

REA's 3Q26 result was driven by a strong yield outcome (+14%) in the resilient domestic residential business, and new listings also returning to growth (+1% on the pcp). FY26 Operating cost guidance being lowered was a key takeaway. We make minor revisions to our FY26-FY28F EPS forecasts (-0.5%) reflecting the lowered cost guidance, offset by a more conservative FY27 yield assumption. Our DCF-derived price target is lowered slightly to A$219 (from A$220). BUY.

SKS’s $22m contract win for the new Coles head office sees the group work in hand expand to $355m ($270m for FY27), with SKS’s Tenders pipeline exceeding $1.2bn (of which >$1bn relates to prospective data centre projects). SKS’s share price momentum increasingly reflects confidence in the group’s strong FY27 outlook, and ability to win a greater share of its healthy pipeline of prospective data centres. We lift our PBT forecasts by ~12-15% in FY27-28F, reflecting our expectations for further conversion of SKS’s share of this pipeline over the year ahead. We retain our ACCUMULATE rating with a revised PT of $8.95/sh.